![Amy Quinlan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Quinlan
Comptroller/Controller/Auditor chez
VOYAGER THERAPEUTICS, INC.
Fortune : 142 219 $ au 31/05/2026
Profil
Amy Quinlan is Chief Accounting Officer at Voyager Therapeutics, Inc. since 2026, with employment at the firm starting in 2025.
Formerly, Ms. Quinlan was Vice President-Finance at Vor Biopharma, Inc. from 2024 to 2025 and Vice President & Controller at Tetraphase Pharmaceuticals, Inc. from 2008 to 2020.
Education includes an undergraduate degree from Bryant University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/05/2026 | 36 749 ( 0,06 % ) | 142 219 $ | 31/05/2026 |
Postes actifs de Amy Quinlan
| Sociétés | Poste | Début |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 08/05/2025 |
Anciens postes connus de Amy Quinlan
| Sociétés | Poste | Fin |
|---|---|---|
| VOR BIOPHARMA INC. | Comptroller/Controller/Auditor | 30/09/2024 |
| TETRAPHASE PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/08/2020 |
Formation de Amy Quinlan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
30
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
Bryant University
 Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
